ALTHOUGH DR3-DQB1-ASTERISK-0201 MAY BE ASSOCIATED WITH MULTIPLE COMPONENT DISEASES OF THE AUTOIMMUNE POLYGLANDULAR SYNDROMES, THE HUMAN-LEUKOCYTE ANTIGEN DR4-DQB1-ASTERISK-0302 HAPLOTYPE IS IMPLICATED ONLY IN BETA-CELL AUTOIMMUNITY
W. Huang et al., ALTHOUGH DR3-DQB1-ASTERISK-0201 MAY BE ASSOCIATED WITH MULTIPLE COMPONENT DISEASES OF THE AUTOIMMUNE POLYGLANDULAR SYNDROMES, THE HUMAN-LEUKOCYTE ANTIGEN DR4-DQB1-ASTERISK-0302 HAPLOTYPE IS IMPLICATED ONLY IN BETA-CELL AUTOIMMUNITY, The Journal of clinical endocrinology and metabolism, 81(7), 1996, pp. 2559-2563
Human leukocyte antigen (HLA)-DRB1 and -DQB1 alleles were analyzed usi
ng a PCR-based sequence-specific priming technique in 16 patients with
autoimmune polyglandular syndrome type I(APS-I), 31 patients with APS
-II, and 110 patients with component diseases of APS-II, including 9 p
atients with isolated Addison's disease, 43 patients with Hashimoto's
thyroiditis, 22 patients with Graves' disease, and 36 patients with vi
tiligo. No significant associations was observed between HLA and APS-I
patients in our data set, nor was sharing of HLA haplotypes by siblin
g pairs affected by APS I significantly different from the random expe
ctation. Thus, HLA-DRB1 and -DQB1 genes are probably not involved in A
PS-I. To delineate the associations between HLA-DRB1, DQB1, and APS-II
, we analyzed APS-II patients with or without beta-cell autoimmunity [
i.e. insulin-dependent diabetes (IDD) and/or islet cell or glutamic ac
id decarboxylase autoantibodies]. Our results suggest that the associa
tion between DR4-DQB10302 and APS-II was entirely due to the presence
of pancreatic p-cell autoimmunity, since this haplotype was otherwise
not significantly associated with APS-II or with any other of its com
ponent diseases. In contrast, the DR3-DQB10201 haplotype was associat
ed not only with IDD, but also with APS-II in the absence of pancreati
c p-cell autoimmunity, as were several its component diseases, includi
ng isolated Addison's disease, Graves' disease, and Hashimoto's thyroi
ditis. Interestingly, the frequency of DQB10602, a dominantly protect
ive allele against IDD, was not significantly decreased in the APS-II
patients with IDD or p-cell autoimmunity, albeit the patient numbers w
ere small. This phenomenon may suggest that the development of autoimm
unity to nonpancreatic endocrine glands may predispose autoimmunity to
the pancreatic p-cells and involve genes other than those of the MHC.